title: Are free fatty acids related to plasma plasminogen activator inhibitor 1 in android obesity?
abstract: Plasminogen activator inhibitor 1 (PAI-1) levels are elevated in obese insulin-resistant subjects. However the mechanism underlying increased PAI-1 levels is unknown. To determine the impact of diabetes on PAI-1 levels and its possible relationship to insulin resistance, hyperinsulinemic euglycemic clamp studies were performed in nine lean control subjects, nine non-diabetic obese subjects and eight obese patients with NIDDM. Fasting plasma PAI-1 levels were 4.0 to 4.7 fold higher in the two obese groups than in the control group. During the 40 mU/m2 x min insulin infusion, suppression of FFA concentration was correlated with fasting plasma PAI-1 levels in both obese non-diabetic and obese NIDDM subjects. It is concluded that (1) obesity rather than diabetes itself plays a major role for the increased PAI-1 levels in NIDDM; (2) resistance to the antilipolytic effect of insulin, resulting in increased FFA concentrations, may participate in producing elevated PAI-1 levels in android obese subjects.
authors.affiliation: Laboratoire de Biochimie B, Hôpital Salpétrière, Paris, France.
authors.forename: J P
authors.initials: JP
authors.lastname: Bastard
authors.forename: E
authors.initials: E
authors.lastname: Bruckert
authors.forename: J J
authors.initials: JJ
authors.lastname: Robert
authors.forename: A
authors.initials: A
authors.lastname: Ankri
authors.forename: A
authors.initials: A
authors.lastname: Grimaldi
authors.forename: C
authors.initials: C
authors.lastname: Jardel
authors.forename: B
authors.initials: B
authors.lastname: Hainque
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D003920:Diabetes Mellitus / Q000097:blood* / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000503:physiopathology; D005215:Fasting / Q000502:physiology; D005230:Fatty Acids, Nonesterified / Q000097:blood / Q000502:physiology*; D005260:Female; D005947:Glucose / Q000378:metabolism; D015309:Glucose Clamp Technique; D006801:Humans; D006946:Hyperinsulinism / Q000097:blood / Q000503:physiopathology; D007333:Insulin Resistance / Q000502:physiology; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000097:blood* / Q000503:physiopathology; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood* / Q000502:physiology
chemical_list: D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D008055:Lipids; D017395:Plasminogen Activator Inhibitor 1; D005947:Glucose